SweDeliver in talks with AstraZeneca about research and continued collaboration

2024-02-09

Wednesday 7 February, Per Hansson, Per Larsson and Göran Frenning, leaders of the SweDeliver Work Packages Parenteral, Oral and Pulmonary drug delivery, visited AstraZeneca to discuss the future of the national competence center. “There is every reason to look forward to a continued positive development,” says Göran Frenning, Professor at Uppsala university.

Per Hansson, Irés van der Zwaan, Sohan Sarangim Göran Frenning, Per Larsson and Staffan Berg
Per Hansson, Irés van der Zwaan, Sohan Sarangim Göran Frenning, Per Larsson and Staffan Berg

 In the new year, the first phase of SweDeliver reaches its goal and discussions are already underway about the national competence center's future development. This week, industrial partner AstraZeneca invited the leaders of the three Work Packages and the visit provided valuable guidance for the upcoming work.

“We went there to identify areas with potential for further development, and on this occasion paid close attention to modelling, artificial intelligence and biopharmaceutics. To me, the talks were both constructive and rewarding for all parties and I look forward to continued discussions,” states Göran Frenning, Professor of Pharmaceutical physics at Uppsala University.

Göran Frenning, The Faculty of Pharmacy
Göran Frenning, The Faculty of Pharmacy

The program also included presentations of the ongoing projects in SweDeliver's three Work Packages, where Per Larsson spoke about Toward double-digit bioavailability: An overview of beyond rule-of-five oral drug delivery research within SweDeliver ,Göran Frenning lectured on From inhalation powders to powder mechanics and Per Hansson on Parenteral delivery: Controlled release and targeting, with focus on subcutaneous administration of protein drugs.

“We provided an overview of the status of the various projects, which was received with great interest. My overall feeling is that we, during our first years, have laid a very solid foundation for what we currently call “SweDeliver 2.0” and that there is every reason to look forward to a continued positive development,” concludes Göran Frenning.

FACTS

  • SweDeliver is a world-leading research and competence center in drug delivery with financial support from Vinnova.
  • SweDeliver focuses on important research challenges in Parenteral, Oral and Pulmonary drug delivery.
  • SweDeliver, with academic hub at Uppsala University's Faculty of Pharmacy, is currently uniting 18 industrial partners.

LEARN MORE

CONTACT

Christel Bergström, professorChristel Bergström, Professor
Center Director, SweDeliver
Uppsala University

Text: Magnus Alsne, photo: Mikael Wallerstedt a o

Currently at SweDeliver

Last modified: 2022-11-16